Drawing for PROJECT GOLD

USPTO serial 98160589

PROJECT GOLD

Reviewed by CopyMark Law Group

Reg. 7584273Status 700Registered
Filing date
Status date
Registration date
Dec 3, 2024
Examiner
DINALLO, KEVIN M
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PROJECT GOLD?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Andrew D. Bochner

Andrew D. Bochner BOCHNER PLLC1040 AVENUE OF THE AMERICAS15TH FLOORNEW YORK, NY 10018

Goods and services

ClassDescriptionStatusFirst use
035Promoting the interests of cancer patients by means of public advocacy, specifically access and availability of generic drugs for cancer treatment; Promoting public awareness of supply chain issues of generic cancer treatment drugs by means of public advocacy; Pharmaceutical cost management services and drug utilization review services, namely, generic drugs for cancer treatment; Providing advertising, marketing and promotional services for the pharmaceutical and medical industry, namely, the manufacture and distribution of generic cancer treatment drugs; Promoting public interest and awareness of availability and accessibility of generic drugs for cancer treatment; Consulting in the field of distributorship services for pharmaceuticals, namely, generic drugs for cancer treatmentACTIVE—
040Consulting services in the field of pharmaceutical manufacturing, namely, generic drugs for cancer treatmentACTIVE—
044Pharmaceutical advice, namely, to facilitate and subsidize access to and availability of generic drugs for cancer treatment; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals, namely, generic drugs for cancer treatmentACTIVE—
045Providing patient advocate services in the field of cancer treatment, namely, increasing access to and availability of generic drugs therefor; Providing patient advocate and case management services, namely, coordinating the procurement and administration of medication, specifically for generic drugs for cancer treatment; Providing information about legal eligibility requirements for government medical and pharmaceutical programs, namely, for access to and availability of generic drugs for cancer treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 3, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 3, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 10, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 10, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 6, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 6, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Aug 6, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 6, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 6, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 5, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 5, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 5, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 4, 2024AAUANOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED—
May 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 3, 2024IUAAUSE AMENDMENT ACCEPTED—
Apr 30, 2024DOCKASSIGNED TO EXAMINER—
Feb 7, 2024AUPCAMENDMENT TO USE PROCESSING COMPLETE—
Feb 7, 2024IUAFUSE AMENDMENT FILED—
Feb 6, 2024EAAUTEAS AMENDMENT OF USE RECEIVED—
Sep 27, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 5, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance